RQ Bio is dedicated to developing treatments and preventative therapies based on potent broad-spectrum mAbs to provide instant and long-lasting immunity for vulnerable people at risk of severe disease or death from existing, emerging and new viral infections.
Location: United Kingdom, England, London
Employees: 1-10
Investors 1
| Date | Name | Website |
| - | Life Arc V... | lifearcven... |
Mentions in press and media 5
| Date | Title | Description | Source |
| 18.03.2024 | RQ Biotechnology Ltd. Celebrates Milestone with Grant of GB ... | RQ Biotechnology Ltd. (“RQ”) a leader in the discovery of antibodies for the treatment of infectious... | lifearcven... |
| 25.01.2024 | Six new investments, portfolio progress and an expanding inv... | Clare Terlouw, Head of LifeArc Ventures, said: “Our portfolio of investments expanded during the yea... | lifearcven... |
| 10.01.2023 | LifeArc portfolio company RQ Bio’s antibody enters clinical ... | LifeArc Ventures’ portfolio company RQ Biotechnology has announced that the first of its discovered ... | lifearc.or... |
| - | AbCellera and RQ Bio Partner | VANCOUVER, British Columbia & LONDON, March 22, 2023 – AbCellera (Nasdaq: ABCL) and RQ Bio annou... | lifearcven... |
| - | LifeArc portfolio company RQ Bio’s antibody enters clinical ... | LifeArc Ventures’ portfolio company RQ Biotechnology has announced that the first of its discovered ... | lifearcven... |